Options: Hide MedDRA Preferred Terms
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Adenoma benign | x | x | x | x | x | x | x | |||||
Anaphylactic shock | x | |||||||||||
Arthritis | x | x | x | x | x | |||||||
Duodenal ulcer | x | x | x | x | x | x | x | x | ||||
Dyspepsia | x | |||||||||||
Erosive oesophagitis | x | x | x | x | x | |||||||
Functional dyspepsia | x | |||||||||||
Gastric ulcer | x | x | x | x | x | x | x | x | x | |||
Gastrinoma | x | x | ||||||||||
Gastrooesophageal reflux disease | x | x | x | x | x | x | x | x | ||||
Haemorrhage | x | |||||||||||
Heartburn | x | x | ||||||||||
Hyperchlorhydria | x | |||||||||||
Pain | x | x | x | x | x | x | x | |||||
Peptic ulcer | x | |||||||||||
Scleroderma | x | x | ||||||||||
Stress ulcer | x | |||||||||||
Systemic mastocytosis | x | x | x | x | x | x | x | |||||
Ulcer | x | x | x | x | x | x | x | |||||
Upper gastrointestinal haemorrhage | x | |||||||||||
Zollinger-Ellison syndrome | x | x | x | x | x | x | x | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |